Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
Monika L. Metzger(St. Jude Children's Research Hospital), Matthew J. Krasin(St. Jude Children's Research Hospital), John T. Lucas(Wake Forest University), Torunn I. Yock(Massachusetts General Hospital), Sarah S. Donaldson(Stanford University), Eric Larsen(University of Massachusetts Chan Medical School), Sandra Luna‐Fineman(Children's Hospital Colorado), Amy L. Billett(Harvard University Press), Jamie E. Flerlage(St. Jude Children's Research Hospital), Nickhill Bhakta(St. Jude Children's Research Hospital), Barry L. Shulkin(St. Jude Children's Research Hospital), Matthew J. Ehrhardt(St. Jude Children's Research Hospital), Pedro de Alarcón(Illinois College), Zhaohua Lu(St. Jude Children's Research Hospital), Melissa M. Hudson(Cincinnati Children's Hospital Medical Center), Chen Li(Hebei General Hospital), Alison M. Friedmann(Harvard University), Michael P. Link(Stanford University), Susan M. Hiniker(Stanford University), Sue C. Kaste(St. Jude Children's Research Hospital), Belinda N. Mandrell(St. Jude Children's Research Hospital)
Cited by 59
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k